Composition containing Pyruvate Dehydrogenase Kinase Inhibitor for treating chronic inflammatory pain

Item Number: 598
Industry: Therapeutic
Category: Inflammation
Development Stage: Early Stage
Organisation Type: University
Country: South Korea
Patent: Korea, USA
Business Opportunity: Out-Licensing, Technology Transfer, Collaboration R&D


The expression of pyruvate dehydrogenase kinase 2/4 was significantly increased in hindpaw of rats that induced chronic inflammatory pain through complete Freund's adjuvant(CFA) injection and it is associated with painful behavior, hindpaw edema and inflammatory response.

Features & Contact

Sign in and you'll be able to send enquiries about this item, view full details and save it